Literature DB >> 28915517

Biallelic Mutations in SLC1A2; an Additional Mode of Inheritance for SLC1A2-Related Epilepsy.

Matias Wagner1,2,3, Mirjana Gusic2, Roman Günthner1,4, Bader Alhaddad1, Reka Kovacs-Nagy1, Christine Makowski5, Friedrich Baumeister6, Tim Strom1,2, Thomas Meitinger1,2, Holger Prokisch1,2, Saskia B Wortmann1,2,7.   

Abstract

Recently, heterozygous de novo mutations in SCL1A2 have been reported to underlie severe early-onset epileptic encephalopathy. In one male presenting with epileptic seizures and visual impairment, we identified a novel homozygous splicing variant in SCL1A2 (c.1421 + 1G > C) by using exome sequencing. Functional studies on cDNA level confirmed a consecutive loss of function. Our findings suggest that not only de novo mutations but also biallelic variants in SLC1A2 can cause epilepsy and that there is an additional autosomal recessive mode of inheritance. These findings also contribute to the understanding of the genetic mechanism of autosomal dominant SLC1A2-related epileptic encephalopathy as they exclude haploinsufficiency as exclusive genetic mechanism. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28915517     DOI: 10.1055/s-0037-1606370

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  5 in total

1.  Recurrent SLC1A2 variants cause epilepsy via a dominant negative mechanism.

Authors:  Andrew B Stergachis; Jonai Pujol-Giménez; Gergely Gyimesi; Daniel Fuster; Giusppe Albano; Marina Troxler; Jonathan Picker; Paul A Rosenberg; Ann Bergin; Jurriaan Peters; Christelle Moufawad El Achkar; Chellamani Harini; Shannon Manzi; Alexander Rotenberg; Matthias A Hediger; Lance H Rodan
Journal:  Ann Neurol       Date:  2019-04-26       Impact factor: 10.422

2.  Results From the WAGR Syndrome Patient Registry: Characterization of WAGR Spectrum and Recommendations for Care Management.

Authors:  Kelly A Duffy; Kelly L Trout; Jennifer M Gunckle; Shari McCullen Krantz; John Morris; Jennifer M Kalish
Journal:  Front Pediatr       Date:  2021-12-14       Impact factor: 3.418

Review 3.  Functional and Biochemical Consequences of Disease Variants in Neurotransmitter Transporters: A Special Emphasis on Folding and Trafficking Deficits.

Authors:  Shreyas Bhat; Ali El-Kasaby; Michael Freissmuth; Sonja Sucic
Journal:  Pharmacol Ther       Date:  2020-12-10       Impact factor: 12.310

4.  Loss of glutamate transporter eaat2a leads to aberrant neuronal excitability, recurrent epileptic seizures, and basal hypoactivity.

Authors:  Adriana L Hotz; Ahmed Jamali; Nicolas N Rieser; Stephanie Niklaus; Ecem Aydin; Sverre Myren-Svelstad; Laetitia Lalla; Nathalie Jurisch-Yaksi; Emre Yaksi; Stephan C F Neuhauss
Journal:  Glia       Date:  2021-10-30       Impact factor: 8.073

Review 5.  Amino Acid Transport Defects in Human Inherited Metabolic Disorders.

Authors:  Raquel Yahyaoui; Javier Pérez-Frías
Journal:  Int J Mol Sci       Date:  2019-12-23       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.